Urolithiasis pp 575-577 | Cite as

The Effects of Various Therapeutic Agents on Urine Composition in Calcium Stone Formers during Follow-Up at an Out-Patient Stone Clinic

  • H.-G. Tiselius
  • K. Sandvall


Several therapeutic regimens have been suggested for the prevention of recurrent renal calcium stone formation. Because a majority of stones produced in this disease is composed of calcium oxalate (CaOx) or mixed CaOx and calcium phosphate, most treatment programs have been designed in order to decrease the risk of CaOx crystallization.


Calcium Phosphate Calcium Oxalate Urinary Stone Urinary Oxalate Calcium Stone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    C Ahlstrand and H-G Tiselius, Metabolic effects of bendroflumethiazide in patients with recurrent calcium oxalate stone disease, J. Urol. 126: 635 (1981).PubMedGoogle Scholar
  2. 2.
    H Bek-Jensen and H-G Tiselius, Stone formation and urine composition in calcium stone formers without medical treatment, submitted for publication (1988).Google Scholar
  3. 3.
    GA Rose, An overview of some problems in urolithiasis, in: “Urinary Stones: Clinical and Laboratory Aspects”, MTP Press, Ltd., Lancaster (1982).Google Scholar
  4. 4.
    H-G Tiselius, An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease, Clin. Chim. Acta 122: 409(1982).PubMedCrossRefGoogle Scholar
  5. 5.
    H-G Tiselius, A Standardized estimate of the ion-activity product of calcium oxalate in urine, submitted for publication (1988).Google Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • H.-G. Tiselius
    • 1
  • K. Sandvall
    • 1
  1. 1.Department of UrologyUniversity HospitalLinköpingSweden

Personalised recommendations